Penn Medicine teams with Independence Blue Cross on primary care venture
Penn Medicine is investing in Independence Blue Cross subsidiary Tandigm Health and adding primary care doctors to Tandigm’s systems, with a statement from CEO Kevin Mahoney.
・ From Philadelphia Inquirer